Seebri Breezhaler Pulver zur Inhalation 30 Kaps

Seebri Breezhaler contains glycopyrronium, a long-acting muscarinic antagonist (LAMA) for the maintenance treatment of COPD. It provides rapid-onset bronchodilation (within five minutes) with sustained 24-hour activity, making it effective for both immediate symptom relief and long-term airway maintenance. The Breezhaler device is a capsule-based dry-powder inhaler with audible and visual feedback confirming correct use.

How to Use Seebri Breezhaler

Inhale one capsule once daily at the same time each day. Place the capsule (grey with white cap) in the Breezhaler device, then press both buttons firmly to pierce the capsule. Breathe out fully, away from the device. Place the mouthpiece in your mouth, close your lips around it, and inhale rapidly and deeply. You should hear a whirring sound, which confirms the capsule is spinning and the dose is being delivered. Hold your breath for a few seconds, then breathe out slowly.

Seebri Breezhaler is a maintenance inhaler for daily use and is not suitable for treating sudden breathlessness. Always keep a fast-acting rescue inhaler available.

One 44 mcg capsule inhaled once daily via the Breezhaler device.

Common Side Effects

Common side effects include:

• Dry mouth
• Nasopharyngitis (runny or blocked nose)
• Insomnia
• Urinary tract infections

As an anticholinergic inhaler, Seebri can occasionally cause urinary retention (difficulty passing urine), particularly in men with an enlarged prostate. Tell your doctor if you have any difficulty urinating. Worsening of narrow-angle glaucoma has been reported, seek immediate medical attention if you experience sudden eye pain or visual disturbances.

Not for acute bronchospasm. Not recommended for asthma. Capsules must not be swallowed. Use with caution in narrow-angle glaucoma and urinary retention.

Contraindicated in known hypersensitivity to glycopyrronium or any excipient.